Semaglutide is the latest treatment for obesity. It is an anti-diabetic medication belonging to a class of drugs known as GLP-1 Receptor Agonists and Incretin Mimetics. Semaglutide was first approved as a treatment for managing blood sugar in Type 2 Diabetes in 2017.

It is similar in the sense they are all prescribed medications with semaglutide as the API (Active Pharmaceutical Ingredient). The three above are patented name brand drugs. Our Semaglutide is compounded in a pharmacy.

Semaglutide, originally developed as a treatment for type 2 diabetes, has gained attention for its effectiveness in weight loss. It works by mimicking a hormone called GLP-1, which helps regulate appetite and food intake. By enhancing feelings of fullness and reducing hunger, semaglutide helps individuals eat less, leading to significant weight loss over time. Clinical trials have shown that it can help people lose a substantial amount of weight when combined with lifestyle changes, making it a promising option for those struggling with obesity.

Semaglutide has proven to be one of the most effective medication for long-term results. It works the same receptors as powerful, naturally-occurring GLP-1 hormones that exist in your body, which improve your metabolic function, and regulate your digestion so you can feel full longer and maximize nutrient absorption.

The recommended dose starts at the .25mg. Patients will increase doses every 4 weeks until they reach the maximum dose of 2.50mg.

The dosing looks like this: .25mg>.50mg>1.00mg>1.50mg>2.00mg.2.50mg.

Never increase prior to 4 weeks and never exceed 2.50mg of Semaglutide.

Semaglutide will be prescribed as a weekly subcutaneous injection. Injections should be administered every 7 days in the abdomen approximately 2-3 inches away from belly button. Make certain to rotate areas. Semaglutide is started at a low dose that is gradually increased so it is important you use the medication exactly as directed. One injection should be administered on the same day each week. Do not increase any dose prior to 4 weeks.

No, semaglutide is not a type of insulin. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the action of the GLP-1 hormone in the body. GLP-1 helps regulate blood sugar levels by stimulating insulin secretion when blood sugar is high, slowing down the release of glucose from the liver, and reducing appetite. While both insulin and semaglutide are used to manage diabetes, they work in different ways. Semaglutide is specifically used to improve blood sugar control and has also been approved for weight management, whereas insulin directly lowers blood sugar by facilitating glucose uptake into cells.

Semaglutide is meant to be titrated up to help minimize negative side effects. Patients begin dosing at 0.25mg for 4 weeks then increase to 0.50mg for 5 weeks then increase again in 4-5 weeks to 1mg. Many individuals find the .50mg - 1.00mg to be the "sweet spot" for weight loss. While others may need the higher doses of 1.50mg - 2.50mg.

Be patient.  Some people do not experience weight loss in the first 4-8 weeks. Everyone is different.  Some people do not experience weight loss until they reach a higher dose of 1.00mg or even 1.50mg.  Do not increase dose prior to 4 weeks.

Yes, it is believed that Semaglutide can help curb your appetite though it is not guaranteed that everyone experiences a curbed appetite. In addition to slowing gastric emptying to make you feel full for longer, GLP-1 also plays a direct role in how your appetite is regulated

Do not increase dose prior to 4 weeks.  The medication is meant to be titrated up every 4 weeks to minimize negative side effects.  It is very important to stay on the recommended dosing schedule.

If you miss a dose and it has been 5-7 days past the due date of your injection, continue at current dose. If you miss a dose and it has been 8-13 days past the due date of your injection, reduce to the previous dose to minimize negative side effects. If you experienced any previous side effects and wish to minimize the reoccurrence of them, you may reduce your dose to .25mg and titrate back up to the desired dose every 4-5 weeks. If you miss a dose and it has been 14+ days past the due date of your injection, start back at .25mg and titrate back up every 4 weeks to the desired dose. 

Stomach flu symptoms--stomach cramps, vomiting, loss of appetite, diarrhea (may be watery or bloody), low blood sugar, upset stomach, heartburn, burping, gas, bloating; nausea, vomiting, stomach pain, loss of appetite; diarrhea, constipation; stomach flu symptoms; headache, dizziness, tiredness.This is not a complete list of side effects and others may occur. Call our physician for medical advice about side effects not listed above.

Most medications do not interfere with Semaglutide but avoid taking any medication including acetaminophen 1 hour prior to your weekly Semaglutide injection.

You should not use semaglutide if you have a personal or family history of multiple medullary thyroid cancer. You have multiple been diagnosed with endocrine neoplasia type 2 (tumors in your glands). Tell your doctor if you suffer from severe gastrointestinal disorders, are pregnant or planning to become pregnant or nursing.

Call your doctor at once if you have signs of a thyroid tumor, such as swelling or a lump in your neck, trouble swallowing, a hoarse voice, or shortness of breath.